Skip to main content
Amyloid imaging and cognitive decline in nondemented oldest-old: the 90+ Study.
- Author(s): Kawas, Claudia H;
- Greenia, Dana E;
- Bullain, Szofia S;
- Clark, Christopher M;
- Pontecorvo, Michael J;
- Joshi, Abhinay D;
- Corrada, María M
- et al.
Published Web Locationhttps://doi.org/10.1016/j.jalz.2012.06.005
BackgroundThe goal of this study was to examine cross-sectional and longitudinal associations between cognitive performance and beta amyloid (Aβ) load determined by florbetapir F18 positron emission tomography (PET) in nondemented oldest-old.
MethodsThirteen nondemented (normal or cognitively impaired nondemented) participants (median age, 94.2 years) from The 90+ Study underwent florbetapir-PET scanning within 3 months of baseline neuropsychological testing. Amyloid load was measured with a semi-automated quantitative analysis of average cortical-to-cerebellar standardized uptake value ratio (SUVr) and a visual interpretation (Aβ- or Aβ+). Neuropsychological testing was repeated every 6 months.
ResultsAt baseline, SUVr correlated significantly with tests of global cognition and memory. During follow-up (median, 1.5 years), the Aβ+ group had steeper declines on most cognitive tests, particularly global cognitive measures.
ConclusionThis preliminary study suggests that greater amyloid load is associated with poorer cognition and faster cognitive decline in nondemented oldest-old. Amyloid load may identify individuals at increased risk of developing Alzheimer's disease.
For improved accessibility of PDF content, download the file to your device.